Diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance in peripheral tissues, particularly muscle and adipose, impairs glucose uptake, leading to hyperglycemia. Insulin's inefficacy stems from receptor and post-receptor defects, increasing blood glucose levels.

• Secondary mechanism: Pancreatic β-cell dysfunction reduces insulin secretion over time. Chronic hyperglycemia and lipotoxicity further stress β-cells, exacerbating insulin deficiency and perpetuating a hyperglycemic state.

• Key complication: Persistent hyperglycemia triggers advanced glycation end-products (AGEs) formation, promoting vascular damage. This contributes to severe complications like diabetic retinopathy, nephropathy, and neuropathy, highlighting the need for stringent glycemic control to prevent morbidity.

Patient Profile

Demographics:

57-year-old male, retired factory worker

History:

• Key past medical history: Type 2 Diabetes Mellitus diagnosed 15 years ago, hypertension, chronic kidney disease stage 3, diabetic neuropathy, and history of myocardial infarction 5 years ago.

• Current medications: Metformin, insulin glargine, lisinopril, atorvastatin, aspirin, gabapentin.

• Allergies: Sulfa drugs

Current Presentation:

• Chief complaint: Shortness of breath and persistent chest pain.

• Key symptoms: Severe fatigue, blurred vision, swelling in lower extremities, frequent urination, and persistent cough.

• Vital signs: BP 180/110 mmHg, HR 120 bpm, RR 28 breaths per minute, Temp 100.4°F, SpO2 88% on room air.

Section 1

The initial assessment reveals that the patient is in acute respiratory distress, likely exacerbated by fluid overload secondary to his compromised renal function and possible heart failure exacerbation. The physical exam shows bilateral crackles in the lungs, indicating pulmonary edema, and pitting edema in the lower extremities. Jugular venous distension is noted, suggesting increased central venous pressure. The patient's skin is warm and flushed, and he appears diaphoretic, indicative of sympathetic nervous system activation due to hypoxia. Neurological assessment reveals decreased sensation in the feet, consistent with diabetic neuropathy, but also raises concern for potential silent myocardial ischemia, given his diabetic status and history of myocardial infarction.

New diagnostic results reveal significant findings. An EKG shows ST-segment depression in the lateral leads, suggesting possible myocardial ischemia. Laboratory tests indicate worsening renal function with an elevated serum creatinine of 2.8 mg/dL and blood urea nitrogen (BUN) of 48 mg/dL. Blood glucose levels are critically high at 350 mg/dL, indicating poor glycemic control. Arterial blood gases (ABG) reveal a pH of 7.32, PaCO2 of 50 mmHg, and HCO3- of 24 mEq/L, suggesting a mixed respiratory and metabolic acidosis. Urinalysis shows significant proteinuria and microalbuminuria, highlighting the progression of diabetic nephropathy. The elevated white blood cell count of 15,000/mm3 and elevated C-reactive protein point to an inflammatory process, possibly pneumonia, contributing to his respiratory symptoms.

The patient's condition necessitates immediate intervention. The focus will be on stabilizing his cardiovascular and respiratory status while addressing his glycemic control and renal function. Intravenous diuretics are initiated to address fluid overload, alongside supplemental oxygen to improve hypoxemia. The insulin regimen is adjusted to target hyperglycemia more aggressively. A cardiology consult is warranted to assess the need for further cardiac intervention, considering his EKG changes and persistent chest pain. The clinical team must also consider initiating or adjusting heart failure management protocols, as well as closely monitoring renal function to prevent further deterioration. The complexity of his condition requires coordinated care across multiple specialties to optimize outcomes and prevent further complications.

Section 2

Response to Interventions

Following the initiation of intravenous diuretics, the patient's respiratory status shows initial signs of improvement, with a reduction in crackles upon auscultation and a slight decrease in jugular venous distention. Oxygen saturation improves from 88% to 92% on 4L/min of supplemental oxygen via nasal cannula. Despite these positive changes, the patient's blood pressure remains elevated at 160/95 mmHg, indicating persistent underlying cardiovascular strain. The adjustment of the insulin regimen begins to yield results, as subsequent blood glucose checks reveal a gradual decline to 280 mg/dL, yet this remains suboptimal, necessitating further titration and monitoring.

However, new complications emerge as the patient begins to exhibit symptoms of confusion and agitation, raising concern for possible hypoglycemia or worsening of his metabolic acidosis. Repeat ABG analysis shows a persistent acidosis with a pH of 7.34, PaCO2 of 48 mmHg, and HCO3- of 22 mEq/L, indicating that the metabolic component has not fully compensated despite respiratory support. The patient's electrolyte panel reveals a serum potassium level of 5.8 mEq/L, suggesting hyperkalemia, likely secondary to renal impairment and necessitating urgent correction to prevent cardiac arrhythmias.

The clinical team must now prioritize addressing the metabolic derangements while ensuring the patient does not develop further electrolyte imbalances. The cardiology consult recommends the urgent initiation of low-dose beta-blockers to manage the suspected silent myocardial ischemia and uncontrolled hypertension, with close monitoring for potential adverse effects given the patient's complex hemodynamic status. Coordination with nephrology is critical to tailor renal support strategies, including the consideration of renal replacement therapy if renal function continues to decline. The unfolding situation demands advanced clinical reasoning to balance interventions effectively while anticipating and mitigating new risks.

Section 3

New Complications

As the clinical team works to stabilize the patient, new complications arise that necessitate immediate attention. Despite the ongoing management strategies, the patient develops acute chest pain, described as a tight, squeezing sensation radiating to the left arm and neck. The patient appears diaphoretic and increasingly tachycardic, with a heart rate climbing to 112 beats per minute. A repeat electrocardiogram (ECG) reveals ST-segment depression in the anterior leads, suggestive of acute coronary syndrome, likely exacerbated by the underlying metabolic and electrolyte imbalances.

Concurrently, the patient experiences a further decline in renal function, as indicated by a rise in serum creatinine to 3.2 mg/dL from a baseline of 1.8 mg/dL, and a decrease in urine output to less than 20 mL/hr. The nephrology team is consulted urgently to evaluate the need for renal replacement therapy. Given the hyperkalemia and worsening renal parameters, the decision is made to initiate emergent hemodialysis to correct the electrolyte abnormalities and mitigate the risk of life-threatening arrhythmias.

In light of these developments, the multidisciplinary team must carefully orchestrate the management of the patient's acute coronary syndrome while addressing the renal crisis. The initiation of hemodialysis poses additional challenges, requiring precise coordination to ensure hemodynamic stability and continuous monitoring of cardiac function. The patient's complex and rapidly evolving condition demands advanced clinical judgment to prioritize interventions and anticipate further complications, all while maintaining a vigilant eye on the delicate balance of therapies being administered.

Section 4

As the patient undergoes emergent hemodialysis, the clinical team closely monitors the response to the intervention. Initially, the patient's blood pressure stabilizes, with readings averaging 128/76 mmHg, and there is a modest improvement in the heart rate, which decreases to 98 beats per minute. Despite these improvements, the patient begins to exhibit signs of respiratory distress. The respiratory rate increases to 28 breaths per minute, and an arterial blood gas analysis reveals a respiratory alkalosis with a pH of 7.48, a partial pressure of carbon dioxide (pCO2) of 30 mmHg, and a partial pressure of oxygen (pO2) of 68 mmHg on room air. Auscultation reveals bilateral crackles at the lung bases, suggesting fluid overload, potentially exacerbated by the aggressive fluid shifts during dialysis.

Concurrently, the patient's latest laboratory results show a potassium level that has decreased to 4.8 mEq/L following dialysis, yet there remains concern due to a persistently elevated creatinine level now at 3.5 mg/dL. Additionally, the patient's hemoglobin has dropped to 9.5 g/dL from a prior 11.2 g/dL, raising concerns about potential gastrointestinal bleeding or hemolysis. The team must now assess the risk of further fluid overload against the need for continued renal support, weighing the possibility of modifying the dialysis regimen to prevent exacerbating the patient's respiratory status.

The multidisciplinary team convenes to re-evaluate the patient's treatment plan, considering the need for supplemental oxygen and potential diuretic therapy to manage the fluid overload. The possibility of a pulmonary consult is discussed to address the respiratory complications, alongside a hematology review to explore the underlying cause of the anemia. The patient's complex clinical picture necessitates a dynamic approach, with continuous reassessment and adaptation of therapeutic strategies to navigate the intersecting challenges of cardiac, renal, and pulmonary dysfunction.

Section 5

As the clinical team deliberates on the management plan, the patient's condition evolves with new diagnostic results that demand immediate attention. A repeat arterial blood gas analysis, conducted after the initiation of supplemental oxygen therapy at 2L via nasal cannula, now reveals a pH of 7.45, pCO2 of 35 mmHg, and pO2 of 75 mmHg. Although there's a slight improvement in oxygenation, the patient's respiratory rate remains elevated at 26 breaths per minute. The auscultation of the lungs continues to reveal bilateral crackles, suggesting unresolved fluid overload. In light of these findings, the team contemplates the addition of a diuretic regimen to facilitate fluid removal, balancing this with the need to preserve intravascular volume to support cardiac output.

The team receives further laboratory results that indicate a concerning trend: the patient's B-type natriuretic peptide (BNP) has surged to 780 pg/mL, reinforcing the suspicion of heart failure exacerbation. Additionally, a stool guaiac test returns positive, hinting at the possibility of occult gastrointestinal bleeding, which could be contributing to the drop in hemoglobin levels. Recognizing the multifaceted nature of the patient's condition, the team prioritizes the stabilization of hemodynamics while expediting consultations with cardiology and gastroenterology to address these emergent issues. The challenge lies in optimizing renal support through dialysis while mitigating cardiac and respiratory compromise, necessitating nuanced clinical judgment and a collaborative multidisciplinary approach.

This new layer of complexity prompts the clinical team to re-evaluate the dialysis protocol, considering a more gradual ultrafiltration rate to prevent further fluid shifts that could exacerbate the respiratory distress. The decision to proceed with diuretic therapy is weighed carefully, aiming for a delicate balance that will alleviate pulmonary congestion without precipitating hypotension. As the team navigates these critical decisions, they remain vigilant for any signs of hemodynamic instability or worsening respiratory status, poised to adjust the therapeutic plan as the patient's response unfolds.